Literature DB >> 8381152

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

N Burdin1, C Péronne, J Banchereau, F Rousset.   

Abstract

Interleukin 10 (IL-10) is a pleiotropic factor that enhances proliferation of activated human B lymphocytes and induces them to secrete high amounts of immunoglobulins. Here we show that several human B cell lines were able to constitutively secrete human (h)IL-10. Whereas none of the pre-B nor the plasmocytic cell lines tested produced hIL-10, 25 of the 36 tested mature B cell lines (lymphoblastoid and Burkitt lymphoma cell lines) secreted hIL-10. Moreover, 24 of these 25 hIL-10-producing B cell lines contained the Epstein-Barr virus (EBV) genome, suggesting a relationship between hIL-10 production by human B cell lines and EBV expression. Accordingly, whereas polyclonal activation via triggering of surface immunoglobulins or CD40 antigen induced highly purified normal human B lymphocytes to produce only low (0.3-0.4 ng/ml) but significant amounts of hIL-10, EBV infection induced them to secrete high amounts of hIL-10 (4-9 ng/ml). Furthermore, addition of exogenous hIL-10, simultaneously to EBV infection, potentiated cell proliferation, whereas a blocking anti-IL-10 antiserum inhibited it. Thus, hIL-10 produced by infected human B lymphocytes appears to be involved in the mechanisms of EBV-induced B cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381152      PMCID: PMC2190909          DOI: 10.1084/jem.177.2.295

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas.

Authors:  T Suda; A O'Garra; I MacNeil; M Fischer; M W Bond; A Zlotnik
Journal:  Cell Immunol       Date:  1990-08       Impact factor: 4.868

2.  Production and regulation of interleukin 6 in human B lymphoid cells.

Authors:  D Hutchins; B B Cohen; C M Steel
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

3.  IL-10, a novel growth cofactor for mature and immature T cells.

Authors:  I A MacNeil; T Suda; K W Moore; T R Mosmann; A Zlotnik
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

4.  Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10.

Authors:  A O'Garra; G Stapleton; V Dhar; M Pearce; J Schumacher; H Rugo; D Barbis; A Stall; J Cupp; K Moore
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

5.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

Authors:  P Vieira; R de Waal-Malefyt; M N Dang; K E Johnson; R Kastelein; D F Fiorentino; J E deVries; M G Roncarolo; T R Mosmann; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

Authors:  A O'Garra; R Chang; N Go; R Hastings; G Haughton; M Howard
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

7.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.

Authors:  F Rousset; E Garcia; J Banchereau
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

9.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.

Authors:  N F Go; B E Castle; R Barrett; R Kastelein; W Dang; T R Mosmann; K W Moore; M Howard
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  59 in total

1.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).

Authors:  S V Kotenko; S Saccani; L S Izotova; O V Mirochnitchenko; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.

Authors:  Giovanni Sais; Stephen Wyler; Tvrtko Hudolin; Irina Banzola; Chantal Mengus; Lukas Bubendorf; Peter J Wild; Hans H Hirsch; Tullio Sulser; Giulio C Spagnoli; Maurizio Provenzano
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation.

Authors:  Emilio Flaño; Basak Kayhan; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy.

Authors:  E Stylianou; P Aukrust; D Kvale; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  DSHP: a "power bar" for sustained immune responses?

Authors:  A B Satterthwaite; D J Rawlings; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient.

Authors:  J Koide; K Takada; M Sugiura; H Sekine; T Ito; K Saito; S Mori; T Takeuchi; S Uchida; T Abe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 7.  Integration of B cell responses through Toll-like receptors and antigen receptors.

Authors:  David J Rawlings; Marc A Schwartz; Shaun W Jackson; Almut Meyer-Bahlburg
Journal:  Nat Rev Immunol       Date:  2012-03-16       Impact factor: 53.106

Review 8.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

9.  Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Authors:  Stefanie Iskra; Markus Kalla; Henri-Jacques Delecluse; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

10.  High levels of circulating IL-10 in human malaria.

Authors:  F Peyron; N Burdin; P Ringwald; J P Vuillez; F Rousset; J Banchereau
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.